SMTL ID : 7voa.1

Crystal structure of SARS-CoV-2 RBD in complex with aRBD5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 7 residues within 4Å: Chain B: F.18, G.19, F.22, N.23, V.47, L.48, S.51 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:F.22, B:V.47, B:L.48 Hydrogen bonds: B:S.51, B:S.51

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, H. et al., Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron. Cell Res. (2022)

Release Date

2022-08-10

Peptides

alpaca nanobody: A
Spike glycoprotein: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

alpaca nanobody

Spike glycoprotein